Business Context and Reporting Period
This Form 8-K is a current report filed by Sunshine Heart, Inc. (not Nuwellis, Inc.) on January 7, 2015, covering events effective January 1, 2015, and January 5, 2015. The filing details significant changes in executive leadership, specifically the appointment of a new Chief Financial Officer and the departure of the prior CFO and Chief Technical Officer.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. It focuses exclusively on executive compensation and separation agreements.
- New CFO Compensation: Annual base salary of $240,000; bonus eligibility up to 25% of base salary plus performance bonus; stock option for 110,000 shares.
- Former CFO Severance: Aggregate payment of $141,594.83; seven-month consulting agreement at $10 per month; 100% COBRA premium coverage for seven months.
- Former CTO Severance: 2014 bonus of $24,157.44; two-year consulting agreement at $18,000 per month for the first 12 months, then $400 per hour.
Material Changes
The primary material change is the turnover of key financial and technical leadership effective early January 2015.
- Appointment: Claudia Drayton was appointed Chief Financial Officer and Secretary effective January 5, 2015. She brings 15 years of experience from Medtronic, Inc.
- Departure: Jeffrey S. Mathiesen departed as CFO and Secretary effective January 5, 2015.
- Departure: Dr. William S. Peters departed as Chief Technical Officer effective January 1, 2015.
Outlook, Risks, and Contingencies
The filing outlines specific contingencies attached to the separation and consulting agreements for the departing executives.
- Contingencies: All severance and consulting payments to Mr. Mathiesen and Dr. Peters are contingent upon their continued compliance with non-disparagement, confidentiality, non-compete, and non-solicitation clauses.
- Equity Vesting: Both departing executives will continue to vest in outstanding equity awards during their respective consulting periods.
- Management Commentary: The filing notes that Ms. Drayton's stock option was granted as a material inducement to enter employment.
Investor Verification Checklist
- Verify the exact closing stock price on January 5, 2015, to determine the exercise price of the 110,000 options granted to Ms. Drayton.
- Confirm the total cash outflow impact of the severance packages ($141,594.83 for Mr. Mathiesen and $24,157.44 for Dr. Peters) in the next quarterly report.
- Review the terms of the consulting agreements to assess the ongoing financial commitment for the seven-month (Mathiesen) and two-year (Peters) periods.
- Check subsequent filings for any updates on the vesting schedules of the departing executives' equity awards.